Related Experiment Video
Updated: Aug 12, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer
Xin Yin1, Kan Jiang1, Ziyang Zhou1
1Department of Radiation Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang 310003, China.
Background:
Ribonucleotide reductase (RR) consists of two subunits, the large subunit RRM1 and the small subunit (RRM2 or RRM2B), which is essential for DNA replication. Dysregulations of RR were implicated in multiple types of cancer. However, the abnormal expressions and biologic functions of RR subunits in liver cancer remain to be elucidated.
Methods:
TCGA, HCCDB, CCLE, HPA, cBioPortal, and GeneMANIA were utilized to perform bioinformatics analysis of RR subunits in the liver cancer. GO, KEGG, and GSEA were used for enrichment analysis.
Results:
The expressions of RRM1, RRM2, and RRM2B were remarkably upregulated among liver cancer tissue both in mRNA and protein levels. High expression of RRM1 and RRM2 was notably associated with high tumor grade, high stage, short overall survival, and disease-specific survival. Enrichment analyses indicated that RRM1 and RRM2 were related to DNA replication, cell cycle, regulation of nuclear division, DNA repair, and DNA recombination. Correlation analysis indicated that RRM1 and RRM2 were significantly associated with several subsets of immune cell, including Th2 cells, cytotoxic cells, and neutrophils. RRM2B expression was positively associated with immune score and stromal score. Chemosensitivity analysis revealed that sensitivity of nelarabine was positively associated with high expressions of RRM1 and RRM2. The sensitivity of rapamycin was positively associated with high expressions of RRM2B.
Conclusion:
Our findings demonstrated high expression profiles of RR subunits in liver cancer, which may provide novel insights for predicting the poor prognosis and increased chemosensitivity of liver cancer in clinic.
Insights
Ribonucleotide reductase (RR) subunits RRM1, RRM2, and RRM2B are highly expressed in liver cancer. Their elevated expression correlates with poor prognosis and predicts chemosensitivity, offering new insights for treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Ribonucleotide reductase (RR) is crucial for DNA replication and its dysregulation is linked to cancer.
- The specific roles and expression patterns of RR subunits (RRM1, RRM2, RRM2B) in liver cancer require further investigation.
Purpose of the Study:
- To investigate the expression profiles and biological functions of RR subunits in liver cancer.
- To explore the prognostic and therapeutic implications of RR subunit expression in liver cancer.
Main Methods:
- Utilized TCGA, HCCDB, CCLE, HPA, cBioPortal, and GeneMANIA for bioinformatics analysis.
- Performed Gene Ontology (GO), KEGG, and Gene Set Enrichment Analysis (GSEA) for enrichment analysis.
Main Results:
- RRM1, RRM2, and RRM2B mRNA and protein levels were significantly upregulated in liver cancer.
- High RRM1/RRM2 expression correlated with advanced tumor grade/stage and poorer survival outcomes.
- RR subunits are implicated in DNA replication, cell cycle, DNA repair, and are associated with immune cell infiltration and chemosensitivity.
Conclusions:
- High expression of RR subunits in liver cancer is associated with poor prognosis.
- RR subunit expression may serve as a predictive biomarker for chemosensitivity in liver cancer treatment.
More Related Videos
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Related Concept Videos
The Nucleolus
Non-LTR Retrotransposons
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...